A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer

NCT06527300 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor (Phase 1)

Interventions

DRUG: NHWD-870 HCl

Sponsor

Zhejiang Wenda Pharma Technology LTD.